Table 2.

Effects of Tirofiban treatment on intracerebral hemorrhage in patients with different ischemic stroke etiology.

	Tirofiban	Without tirofiban	P value	Adjusted OR (95% CI) and P value
ALL PATIENTS*
Sich	3/71 (4.2)	14/124 (11.3)	0.092	0.374 (0.102–1.374), 0.138
In-hospital ICH	13/71 (18.3)	42/124 (33.9)	0.020	0.382 (0.180–0.809), 0.012
LARGE ARTERY ATHEROSCLEROSIS#
sICH	2/39 (5.1)	6/56 (10.7)	0.464	0.529 (0.093–3.000), 0.472
In-hospital ICH	4/39 (10.3)	18/56 (32.1)	0.013	0.280 (0.081–0.967), 0.044
CARDIOEMBOLISM$
sICH	1/28 (3.6)	5/56 (8.9)	0.658	0.317 (0.029–3.482), 0.347
In-hospital ICH	9/28 (32.1)	19/56 (33.9)	0.870	0.692 (0.228–2.099), 0.516

^*Adjusted for age, gender, NIHSS on admission, previous TIA/stroke, intravenous thrombolysis.

^#Adjusted for age, gender, NIHSS on admission, smoking, diabetes mellitus.

^$Adjusted for age, gender, NIHSS on admission, smoking, previous TIA/stroke, intravenous thrombolysis.

sICH, indicates symptomatic intracerebral hemorrhage; ICH, intracerebral hemorrhage.